RUBY

Rubius Therapeutics, Inc

Delisted

RUBY was delisted on the 6th of March, 2023.

117 hedge funds and large institutions have $494M invested in Rubius Therapeutics, Inc in 2022 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 39 increasing their positions, 33 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
117
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$4.78M
Puts
$556K
Net Calls
Net Calls Change

Top Sellers

1 -$6.48M
2 -$5.05M
3 -$1.16M
4
UBS Group
UBS Group
Switzerland
-$607K
5
Citigroup
Citigroup
New York
-$578K
Name Holding Trade Value Shares
Change
Change in
Stake
51
$307K
52
$304K
53
$302K
54
$289K
55
$276K
56
$258K
57
$242K
58
$231K
59
$231K
60
$208K
61
$201K
62
$177K
63
$174K
64
$170K
65
$168K
66
$159K
67
$159K
68
$158K
69
$147K
70
$133K
71
$126K
72
$117K
73
$116K
74
$113K
75
$104K